Loading...
Back to narrative

Update shared on21 Sep 2025

Fair value Increased 2.41%
AnalystConsensusTarget's Fair Value
JP¥4,250.91
14.7% undervalued intrinsic discount
21 Sep
JP¥3,624.00
Loading
1Y
-3.8%
7D
-3.9%

The upward revision in Mitsui Chemicals’ price target is underpinned by a marginal improvement in consensus revenue growth forecasts and a slightly higher expected future P/E, resulting in the fair value estimate increasing from ¥4151 to ¥4251.


What's in the News


  • Revised H1 2025 earnings guidance: sales revenue JPY 818.0 billion, operating income JPY 31.0 billion, net income JPY 7.5 billion, basic EPS JPY 40.03.
  • Board meeting held to consider disposal of treasury shares as restricted stock-based compensation.

Valuation Changes


Summary of Valuation Changes for Mitsui Chemicals

  • The Consensus Analyst Price Target has risen slightly from ¥4151 to ¥4251.
  • The Consensus Revenue Growth forecasts for Mitsui Chemicals has risen from 2.2% per annum to 2.4% per annum.
  • The Future P/E for Mitsui Chemicals has risen slightly from 11.35x to 11.71x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.